123456
123456

New perspectives for cancer therapy

Immunotherapy for cancer at the IOZK in Cologne

In recent decades, the field of tumor immunology has been the subject of intensive research worldwide. The Nobel Prize in Medicine was awarded in 2011 and 2018 for discoveries in immuno-oncology, demonstrating the outstanding importance of this discipline. Since 1985, our physicians and scientists at the Immun-Onkologisches Zentrum Köln (IOZK) have been studying the role of the immune system in cancer and chronic infectious diseases.

As part of this process, we developed IOZK immunotherapy for cancer. Our experience with this therapy shows us that we are on the right track: this treatment method allows us to offer our patients a customized therapy that offers good prospects for gentle treatment and the highest possible quality of life.

From the outset, we have been convinced by the multifaceted qualities of immunotherapy. It aims to strengthen and activate the patient's own immune system in the fight against cancer. In the best-case scenario, it provides long-term protection against new cancer cells. In contrast, surgery, chemotherapy, and radiation therapy aim to destroy the tumor through surgery or medication—often with serious side effects for healthy cells and the immune system.

We are striving to further develop IOZK immunotherapy in line with the latest findings in immuno-oncology. We can already offer this treatment to tumor patients today—even though it is not yet a standard treatment.

Depending on the terms of the contract, the costs are covered by some private health insurance companies or professional associations.

INSIGHTS

The IOZK and IOZK immunotherapy against cancer.

This film provides brief information about the team, the clinic, the laboratories, and the main components of IOZK immunotherapy for cancer.
Duration: 7 min

You can find more videos and patient testimonials on our video channel.

To the video channel
WHAT WE DO

How IOZK immunotherapy works.

The goal of IOZK immunotherapy is to enable the patient's own immune system to specifically kill tumor cells in the body or hinder their growth.

IOZK Immunotherapy

WHO WE HELP

For which types of cancer can IOZK immunotherapy be used to treat cancer?

Experience from numerous therapies shows that immuno-oncological therapies are effective across indications, i.e., for a wide variety of tumor types, and are comparatively well tolerated.

Here you will find specific information on the treatment of different types of cancer:

Course of treatment by cancer type
HOW IT WORKS

How we manage to get our own immune system to fight tumor cells.

The IO-VAC® tumor vaccine activates the patient's immune system so that it can fight the cancer cells itself. To do this, the vaccine uses the patient's own dendritic cells, tumor antigens, and oncolytic viruses. 

IO-VAC® vaccine
WHO WE ARE

Specialized physicians and renowned scientists are committed to providing optimal treatment.

The medical and scientific experts, together with the laboratory staff and the nursing team, care for patients from all over the world. This interdisciplinary collaboration offers patients valuable treatment benefits.

The IOZK Team
CONTACT

Modern cancer treatment in the heart of Cologne

The IOZK is a treatment center with its own laboratory in the center of Cologne. In addition to examination and treatment rooms, conference rooms, administrative offices, and modern laboratories of the highest quality, the center covers an area of 2,300 square meters.

+49 221 420 399 25
info@iozk.de

From the section: Expertise

What is immunotherapy?

The immune system is the guardian of our health. Its main function is to distinguish between what is foreign and what is harmless, and what is dangerous. When a tumor develops, these control mechanisms of the immune system fail, so that it can no longer effectively perform its guardian function. The goal of immunological therapy is to "train" the patient's immune system so that it can fight tumor growth on its own.
Learn more about the theoretical background in our article.

Immunotherapy against cancer

Dr. Wilfried Stücker – International expert in oncology

The doctor and clinic portal provides information about specialist clinics and medical experts. The Leading Medicine Guide only lists proven experts who meet the following strict admission criteria.

  • At least 10 years of surgical and treatment experience
  • Mastery of modern diagnostic and surgical procedures
  • Outstanding treatment focus within one's own field of expertise
  • Member of a leading national professional association
  • Senior professional position
  • Active participation in professional events
  • Active in research and teaching
  • Evaluated quality management
To the Leading Medicine Guide

The importance of dendritic cells

Dendritic cells play a key role in IOZK immunotherapy. They can initiate and regulate immune responses. This ability can be used to generate immune responses against specific proteins in tumor cells, thereby enabling the immune system to fight tumors. Dendritic cells are extracted from the patient's blood to generate the patient's own tumor vaccine, IO-VAC®.

You are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information
Unblock content Accept required service and unblock content
Dendritic cells

News

IOZK patient brochure

Our patient brochure provides concise information about the IOZK and IOZK immunotherapy. It is available in several languages.

IOZK patient brochure